Anglo American Platinum Limited - ANGPY

ANGPY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ANGPY	1.8	0.7	4.4	-12.6	0.7	-19.0	-71.7	-60.9	1.3	62.5
S&P 500	0.9	1.4	2.0	3.3	9.9	24.7	37.5	82.2	197.7	34153.9

Compare ANGPY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ANGPY
name	Anglo American Platinum Limited
price	5.64
changes percentage	1.8051
change	0.1
day low	5.6
day high	5.75
year high	7.69
year low	4.8
market cap	8906215971
price avg 50	5.67352
price avg 200	6.02718
exchange	PNK
volume	17568
avg volume	186545
open	5.75
previous close	5.54
eps	0.39
pe	14.46
earnings announcement	2025-02-06T10:59:00.000+0000
shares outstanding	1579116307
timestamp	2025-01-21 20:57:23

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 43.7%

Overall Quarterly Financial Health: 63.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	124583000000	164090000000	-24.08
gross profit	21013000000	70512000000	-70.20
gross profit ratio	0.17	0.43	-60.75
research and development expenses	196000000	171000000	14.62
operating expenses	2045000000	1442000000	41.82
interest income	1191000000	966000000	23.29
interest expense	645000000	381000000	69.29
ebitda	25034000000	72896000000	-65.66
ebitdaratio	0.2	0.46	-56.45
operating income	18378000000	69916000000	-73.71
operating income ratio	0.15	0.43	-65.38
net income	13040000000	49153000000	-73.47
net income ratio	0.1	0.3	-65.06
eps	49.47	31.07	59.22

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 124,583 million in 2023 from 164,090 million in 2022 representing a change of -24.08%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 21,013 million in 2023 from 70,512 million in 2022 representing a change of -70.2%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 2,045 million in 2023 from 1,442 million in 2022 representing a change of 41.82%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 25,034 million in 2023 from 72,896 million in 2022 representing a change of -65.66%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 18,378 million in 2023 from 69,916 million in 2022 representing a change of -73.71%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 13,040 million in 2023 from 49,153 million in 2022 representing a change of -73.47%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 196 million in 2023 from 171 million in 2022 representing a change of 14.62%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Earnings per Share (EPS): EPS increased to 49.47 in 2023 from 49.47 in 2022 representing a change of 59.22%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	52213000000	59906000000	-12.84
gross profit	11362000000	10084000000	12.67
gross profit ratio	0.22	0.17	29.27
research and development expenses	74000000	129000000	-42.64
operating expenses	2837000000	3243000000	-12.52
interest income	171000000	340000000	-49.71
interest expense	0	0	NaN
ebitda	13991000000	11800000000	18.57
ebitdaratio	0.27	0.2	36.04
operating income	10459000000	8456000000	23.69
operating income ratio	0.2	0.14	41.91
net income	6321000000	5299000000	19.29
net income ratio	0.12	0.09	36.86
eps	23.99	3.36	613.99

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 52,213 million in 2024Q2 from 59,906 million in 2023Q4 representing a change of -12.84%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Income: Operating income decreased to 10,459 million in 2024Q2 from 8,456 million in 2023Q4 representing a change of 23.69%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 11,362 million in 2024Q2 from 10,084 million in 2023Q4 representing a change of 12.67%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 74 million in 2024Q2 from 129 million in 2023Q4 representing a change of -42.64%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 2,837 million in 2024Q2 from 3,243 million in 2023Q4 representing a change of -12.52%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 13,991 million in 2024Q2 from 11,800 million in 2023Q4 representing a change of 18.57%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 6,321 million in 2024Q2 from 5,299 million in 2023Q4 representing a change of 19.29%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 23.99 in 2024Q2 from 23.99 in 2023Q4 representing a change of 613.99%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	169215000000	176914000000	-4.35
total liabilities	69180000000	79952000000	-13.47
total equity	100035000000	96962000000	3.17
cash and cash equivalents	23078000000	28303000000	-18.46
short term investments	1599000000	3338000000	-52.10
long term investments	4218000000	2963000000	42.36
total current assets	69583000000	89710000000	-22.44
total non current assets	99632000000	87204000000	14.25
total current liabilities	46939000000	58057000000	-19.15
total non current liabilities	22241000000	21895000000	1.58
common stock	26000000	26000000	0.00
retained earnings	70461000000	69488000000	1.40
total debt	7631000000	458000000	1566.16

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 169,215 million in 2023 from 176,914 million in 2022 representing a change of -4.35%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 23,078 million in 2023 from 28,303 million in 2022 representing a change of -18.46%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 1,599 million in 2023 from 3,338 million in 2022 representing a change of -52.1%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 69,583 million in 2023 from 89,710 million in 2022 representing a change of -22.44%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 7,631 million in 2023 from 458 million in 2022 representing a change of 1566.16%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 69,180 million in 2023 from 79,952 million in 2022 representing a change of -13.47%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 100,035 million in 2023 from 96,962 million in 2022 representing a change of 3.17%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 46,939 million in 2023 from 58,057 million in 2022 representing a change of -19.15%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 70,461 million in 2023 from 69,488 million in 2022 representing a change of 1.4%. This indicates an accumulated profits.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	179013000000	169215000000	5.79
total liabilities	75485000000	69180000000	9.11
total equity	103528000000	100035000000	3.49
cash and cash equivalents	26892000000	23078000000	16.53
short term investments	0	1599000000	-100.00
long term investments	3673000000	4218000000	-12.92
total current assets	69100000000	69583000000	-0.69
total non current assets	109913000000	99632000000	10.32
total current liabilities	51638000000	46939000000	10.01
total non current liabilities	23847000000	22241000000	7.22
common stock	26000000	26000000	0.00
retained earnings	73898000000	70461000000	4.88
total debt	11463000000	7631000000	50.22

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 179,013 million in 2024Q2 from 169,215 million in 2023Q4 representing a change of 5.79%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 103,528 million in 2024Q2 from 100,035 million in 2023Q4 representing a change of 3.49%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 26,892 million in 2024Q2 from 23,078 million in 2023Q4 representing a change of 16.53%. This indicates an increase in available liquid assets.

  Retained Earnings: Retained Earnings increased to 73,898 million in 2024Q2 from 70,461 million in 2023Q4 representing a change of 4.88%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 75,485 million in 2024Q2 from 69,180 million in 2023Q4 representing a change of 9.11%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q2 from 1,599 million in 2023Q4 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 69,100 million in 2024Q2 from 69,583 million in 2023Q4 representing a change of -0.69%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 51,638 million in 2024Q2 from 46,939 million in 2023Q4 representing a change of 10.01%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 11,463 million in 2024Q2 from 7,631 million in 2023Q4 representing a change of 50.22%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-5240000000	-21890000000	76.06
operating cash flow	16554000000	45358000000	-63.50
free cash flow	-4338000000	28462000000	-115.24
capital expenditure	-20892000000	-16896000000	-23.65
depreciation and amortization	6331000000	5795000000	9.25
deferred income tax	0	0	NaN
stock based compensation	297000000	262000000	13.36
accounts payables	0	1340000000	-100.00
inventory	13752000000	-10472000000	231.32
acquisitions net	-515000000	-113000000	-355.75
investments in property plant and equipment	-20892000000	-16896000000	-23.65
net cash used for investing activites	-16296000000	-10958000000	-48.71
debt repayment	7035000000	-49000000	14457.14
common stock issued	-169000000	0	NaN
common stock repurchased	-169000000	-165000000	-2.42
dividends paid	-12149000000	-54601000000	77.75
net cash used provided by financing activities	-7748000000	-57516000000	86.53
cash at end of period	24353000000	29593000000	-17.71
accounts receivables	-1990000000	-1340000000	-48.51
cash at beginning of period	29593000000	51483000000	-42.52

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -5,240 million in 2023 from -21,890 million in 2022 representing a change of 76.06%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -20,892 million in 2023 from -16,896 million in 2022 representing a change of -23.65%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 1,340 million in 2022 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -1,990 million in 2023 from -1,340 million in 2022 representing a change of -48.51%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -12,149 million in 2023 from -54,601 million in 2022 representing a change of 77.75%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 16,554 million in 2023 from 45,358 million in 2022 representing a change of -63.5%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -4,338 million in 2023 from 28,462 million in 2022 representing a change of -115.24%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 297 million in 2023 from 262 million in 2022 representing a change of 13.36%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	11090943079	6857752391	61.73
free cash flow	2784805830	-5157658169	153.99
capital expenditure	-8306137248	-12015410561	30.87
depreciation and amortization	3468454420	3283328835	5.64
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-2402426112	-2764532211	13.10
accounts payables	-232710878	2533245959	-109.19
inventory	-954983682	5177184588	-118.45
acquisitions net	245263751	-74515165	429.15
investments in property plant and equipment	-8306137248	-12015410561	30.87
net cash used for investing activites	-8054114235	-12252648548	34.27
debt repayment	199875407	-19634943	1117.96
common stock issued	0	-51495091	100.00
common stock repurchased	-140978368	-149312189	5.58
dividends paid	-2382148400	-2835654246	15.99
net cash used provided by financing activities	-166000000	-3496956337	95.25
net change in cash	26892000000	-7904904673	440.19
cash at end of period	26637807259	24198544762	10.08
cash at beginning of period	0	32103449436	-100.00

Overall Score of Quarterly Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 26,892 million in 2024Q2 from -7,905 million in 2023Q4 representing a change of 440.19%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 11,091 million in 2024Q2 from 6,858 million in 2023Q4 representing a change of 61.73%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 2,785 million in 2024Q2 from -5,158 million in 2023Q4 representing a change of 153.99%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 233 million in 2024Q2 from 2,533 million in 2023Q4 representing a change of -109.19%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -2,382 million in 2024Q2 from -2,836 million in 2023Q4 representing a change of 15.99%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -8,306 million in 2024Q2 from -12,015 million in 2023Q4 representing a change of 30.87%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to -2,402 in 2024Q2 from -2,765 million in 2023Q4 representing a change of 13.1%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q2 2022 Earnings call transcript
Q4 2021 Earnings call transcript
Q2 2021 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	473.15	623.17	-24.07
net income per share	49.52	186.67	-73.47
operating cash flow per share	62.87	172.26	-63.50
free cash flow per share	-16.48	108.09	-115.24
cash per share	93.72	120.16	-22.01
book value per share	379.92	368.24	3.17
tangible book value per share	378.41	366.73	3.18
shareholders equity per share	378.31	367.53	2.93
interest debt per share	31.43	3.19	886.43
market cap	253822755122.48	375186852729.67	-32.35
enterprise value	238375755122.48	347341852729.67	-31.37
pe ratio	19.46	7.63	155.01
price to sales ratio	2.04	2.29	-10.89
pocfratio	15.33	8.27	85.37
pfcf ratio	-58.51	13.18	-543.87
pb ratio	2.55	3.88	-34.27
ptb ratio	2.55	3.88	-34.27
ev to sales	1.91	2.12	-9.61
enterprise value over ebitda	9.59	4.75	101.95
ev to operating cash flow	14.4	7.66	88.04
ev to free cash flow	-54.95	12.2	-550.28
earnings yield	0.05	0.13	-60.79
free cash flow yield	-0.02	0.08	-122.53
debt to equity	0.08	0.0	1518.72
debt to assets	0.05	0.0	1641.96
net debt to ebitda	-0.62	-0.38	-63.24
current ratio	1.48	1.55	-4.06
interest coverage	29.46	183.51	-83.95
income quality	0.91	0.68	34.56
dividend yield	0.05	0.15	-67.11
payout ratio	0.93	1.11	-16.13
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.0	0.0	50.97
intangibles to total assets	0.0	0.0	4.55
capex to operating cash flow	1.26	0.37	238.80
capex to revenue	0.17	0.1	62.86
capex to depreciation	3.3	2.92	13.18
stock based compensation to revenue	0.0	0.0	49.31
graham number	649.27	1242.45	-47.74
roic	0.11	0.43	-74.89
return on tangible assets	0.08	0.28	-72.26
graham net net	-93.52	-82.32	-13.60
working capital	22644000000	31653000000	-28.46
tangible asset value	99638000000	96565000000	3.18
net current asset value	403000000	9758000000	-95.87
invested capital	115539000000	111215000000	3.89
average receivables	2604000000	2399500000	8.52
average payables	19671000000	20122500000	-2.24
average inventory	42606500000	43251500000	-1.49
days sales outstanding	6.79	6.43	5.64
days payables outstanding	62.33	84.47	-26.21
days of inventory on hand	127.85	190.87	-33.01
receivables turnover	53.75	56.78	-5.34
payables turnover	5.86	4.32	35.52
inventory turnover	2.85	1.91	49.28
roe	0.13	0.51	-74.23
capex per share	79.34	64.17	23.65

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 19.46 on 2023-12-31 from 7.63 on 2022-12-31, representing a change of 155.01%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.48 on 2023-12-31 from 1.55 on 2022-12-31, representing a change of -4.06%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.08 on 2023-12-31 from 0.00 on 2022-12-31, representing a change of 1518.72%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
ANGPY
calendar year	2024	2023	NaN
revenue per share	198.45	227.59	-12.80
net income per share	24.03	20.13	19.34
operating cash flow per share	41.77	27.82	50.18
free cash flow per share	9.08	-19.95	145.51
cash per share	95.78	93.75	2.16
book value per share	393.49	380.04	3.54
tangible book value per share	391.98	378.53	3.55
shareholders equity per share	392.27	378.43	3.66
interest debt per share	52.66	30.95	70.16
market cap	149569719000	253741434733.66	-41.05
enterprise value	135739719000	238294434733.66	-43.04
pe ratio	5.92	11.97	-50.58
price to sales ratio	2.86	4.24	-32.37
pocfratio	13.61	34.65	-60.73
pfcf ratio	62.61	-48.31	229.59
pb ratio	1.45	2.55	-43.11
ptb ratio	1.45	2.55	-43.11
ev to sales	2.6	3.98	-34.64
enterprise value over ebitda	9.7	20.91	-53.60
ev to operating cash flow	12.35	32.54	-62.05
ev to free cash flow	56.82	-45.37	225.23
earnings yield	0.04	0.02	102.37
free cash flow yield	0.02	-0.02	177.17
debt to equity	0.13	0.08	65.21
debt to assets	0.07	0.05	61.80
net debt to ebitda	-0.99	-1.36	27.07
current ratio	1.34	1.48	-9.73
interest coverage	13.45	16.41	-18.08
income quality	1.74	1.38	25.84
dividend yield	0.02	0.01	32.99
payout ratio	0.39	0.59	-34.28
sales general and administrative to revenue	0.0	0.0	-88.19
research and ddevelopement to revenue	0.0	0.0	-34.18
intangibles to total assets	0.0	0.0	-5.47
capex to operating cash flow	0.78	1.72	-54.43
capex to revenue	0.16	0.21	-21.51
capex to depreciation	2.44	3.72	-34.57
stock based compensation to revenue	0.0	0.0	37.99
graham number	460.49	414.02	11.22
roic	0.06	0.05	15.32
return on tangible assets	0.04	0.03	12.74
graham net net	-113.25	-93.55	-21.06
working capital	17462000000	22644000000	-22.88
tangible asset value	103131000000	99638000000	3.51
net current asset value	-6385000000	403000000	-1684.37
invested capital	115529000000	115539000000	-0.01
average receivables	4290000000	3200000000	34.06
average payables	17143500000	16389000000	4.60
average inventory	33932000000	38935500000	-12.85
days sales outstanding	10.79	3.48	209.95
days payables outstanding	36.57	32.0	14.29
days of inventory on hand	69.59	65.64	6.01
receivables turnover	8.34	25.84	-67.74
payables turnover	2.46	2.81	-12.51
inventory turnover	1.29	1.37	-5.67
roe	0.06	0.05	15.13
capex per share	32.69	47.77	-31.56

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 5.92 on 2024-06-30 Q2 from 11.97 on 2023-12-31 Q4, representing a change of -50.58%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.34 on 2024-06-30 Q2 from 1.48 on 2023-12-31 Q4, representing a change of -9.73%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.13 on 2024-06-30 Q2 from 0.08 on 2023-12-31 Q4, representing a change of 65.21%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None